
Therapeutic Area | MeSH |
|---|---|
| signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| OXYCODONE HYDROCHLORIDE | Genus Lifesciences | N-200534 RX | 2010-10-20 | 1 products, RLD, RS |
| OXYCODONE HYDROCHLORIDE | Genus Lifesciences | N-200535 RX | 2010-10-20 | 2 products, RLD, RS |
| ROXYBOND | Protega Pharmaceuticals | N-209777 RX | 2017-04-20 | 4 products |
| OXYCONTIN | Purdue Pharma | N-022272 RX | 2010-04-05 | 7 products, RLD |
| ROXICODONE | SPECGX | N-021011 RX | 2000-08-31 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TARGINIQ | Purdue Pharma | N-205777 DISCN | 2014-07-23 | 3 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| XARTEMIS XR | Mallinckrodt | N-204031 DISCN | 2014-03-11 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| COMBUNOX | Forest Laboratories | N-021378 DISCN | 2004-11-26 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| XTAMPZA ER | Collegium Pharmaceutical | N-208090 RX | 2016-04-26 | 5 products, RLD, RS |
Brand Name | Status | Last Update |
|---|---|---|
| endocet | ANDA | 2025-08-28 |
| endodan | NDA authorized generic | 2011-05-23 |
| nalocet | ANDA | 2024-08-06 |
| oxaydo | New Drug Application | 2025-08-19 |
| oxycodone | ANDA | 2022-09-22 |
| oxycodone and acetaminophen | ANDA | 2025-10-28 |
| oxycodone and acetaminophen oxycodone hydrochloride | ANDA | 2025-06-05 |
| oxycodone and aspirin | ANDA | 2023-09-18 |
| oxycodone hcl | ANDA | 2025-07-22 |
| oxycodone hcl controlled-release | New Drug Application | 2010-01-14 |
Expiration | Code | ||
|---|---|---|---|
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, GENUS LIFESCIENCES | |||
| 2024-07-21 | M-14 | ||
OXYCODONE HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, VISTAPHARM | |||
| 2024-07-21 | M-14 | ||
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Oxycodone, Xtampza Er, Collegium Pharm Inc | |||
| 9737530 | 2036-09-02 | DP | U-1556 |
| 9968598 | 2036-09-02 | DP | U-1556 |
| 10188644 | 2036-09-02 | DP | U-1556 |
| 10646485 | 2036-09-02 | DP | U-1556 |
| 9682075 | 2030-12-10 | DP | U-1556 |
| 10004729 | 2030-12-10 | DP | U-1556 |
| 10668060 | 2030-12-10 | DP | U-1556 |
| 8758813 | 2025-06-10 | U-1556 | |
| 7399488 | 2025-03-24 | DP | |
| 7771707 | 2025-03-24 | DP | |
| 8449909 | 2025-03-24 | DP | |
| 8557291 | 2025-03-21 | DP | |
| Acetaminophen / Oxycodone Hydrochloride, Xartemis Xr, Mallinckrodt Inc | |||
| 8658631 | 2032-05-16 | DP | |
| 8741885 | 2032-05-16 | DP | U-1499 |
| 8992975 | 2032-05-16 | DP | |
| 9050335 | 2032-05-16 | DP | |
| 9468636 | 2032-05-16 | U-1499 | |
| 8597681 | 2030-12-21 | DP | |
| 8980319 | 2030-12-21 | DP | |
| 8377453 | 2029-11-19 | DP | U-1499 |
| 8372432 | 2029-03-11 | DP | U-1499 |
| 8394408 | 2029-03-11 | DP | |
| 8668929 | 2029-03-11 | U-1499 | |
| 7976870 | 2027-06-01 | U-1498 | |
| Oxycodone Hydrochloride, Oxycontin, Purdue Pharma Lp | |||
| 8894987 | 2030-03-29 | DP | |
| 8808741 | 2027-08-24 | U-1556 | |
| 8894988 | 2027-08-24 | DP | |
| 9492389 | 2027-08-24 | DP | |
| 9492391 | 2027-08-24 | U-1556 | |
| 9492392 | 2027-08-24 | DP | |
| 9492393 | 2027-08-24 | U-1556 | |
| 9763933 | 2027-08-24 | DP | |
| 9770416 | 2027-08-24 | DP | |
| 9775808 | 2027-08-24 | DP | |
| 11304908 | 2027-08-24 | DP | |
| 11304909 | 2027-08-24 | U-1556 | |
| 10407434 | 2025-03-30 | DP | |
| 10696684 | 2025-03-30 | DP | |
| Oxycodone Hydrochloride, Roxybond, Protega Pharms | |||
| 7955619 | 2028-08-12 | DP | |
| 10314788 | 2028-08-12 | DP | |
| Naltrexone Hydrochloride / Oxycodone Hydrochloride, Troxyca Er, Pfizer | |||
| 7815934 | 2027-12-12 | DP | |
| 8685443 | 2025-07-03 | U-1508 | |
| Naloxone Hydrochloride / Oxycodone Hydrochloride, Targiniq, Purdue Pharma Lp | |||
| 9073933 | 2025-03-30 | DP | |
| 9522919 | 2025-03-30 | DS, DP | |
| Oxycodone Hydrochloride, Oxaydo, Zyla | |||
| 7201920 | 2025-03-16 | DP | |
| 9492443 | 2024-05-26 | DP | |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postoperative pain | D010149 | — | G89.18 | 6 | 8 | 33 | 68 | 54 | 168 |
| Pain | D010146 | EFO_0003843 | R52 | 14 | 13 | 38 | 28 | 28 | 120 |
| Chronic pain | D059350 | — | — | 7 | 7 | 9 | 12 | 9 | 44 |
| Healthy volunteers/patients | — | — | — | 41 | 1 | — | 2 | 1 | 44 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 11 | 13 | 1 | 8 | 11 | 43 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | 1 | 6 | 12 | 11 | 3 | 33 |
| Cancer pain | D000072716 | — | G89.3 | — | 6 | 7 | 10 | 5 | 28 |
| Low back pain | D017116 | — | M54.5 | 1 | 1 | 15 | 7 | 4 | 28 |
| Back pain | D001416 | — | M54 | — | 1 | 18 | 6 | 3 | 28 |
| Acute pain | D059787 | — | R52 | 5 | 3 | 6 | 4 | 10 | 28 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Anesthesia | D000758 | — | — | — | 1 | 1 | — | 7 | 8 |
| Hip osteoarthritis | D015207 | EFO_1000786 | M16 | — | — | 2 | — | 5 | 7 |
| Replacement arthroplasty knee | D019645 | — | — | 1 | — | 1 | — | 3 | 5 |
| Arthralgia | D018771 | — | M25.5 | — | 1 | 3 | — | — | 4 |
| Neoplasm metastasis | D009362 | EFO_0009708 | — | 1 | — | 1 | — | 1 | 3 |
| Joint diseases | D007592 | — | M12.9 | — | — | 2 | — | 1 | 3 |
| Mucositis | D052016 | EFO_1001898 | — | 1 | — | 1 | — | 1 | 3 |
| Ankle injuries | D016512 | — | S93.4 | — | — | 2 | — | 1 | 3 |
| Arthroplasty | D001178 | — | — | — | — | 1 | — | 1 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Emergencies | D004630 | — | — | — | 1 | — | — | 4 | 5 |
| Lung neoplasms | D008175 | — | C34.90 | 1 | 2 | — | — | 1 | 4 |
| Drug interactions | D004347 | — | — | 1 | 1 | — | — | 2 | 3 |
| Anesthesia and analgesia | D000760 | — | — | 2 | 2 | — | — | 1 | 3 |
| Syndrome | D013577 | — | — | — | 1 | — | — | 1 | 2 |
| Adenoidectomy | D000233 | — | — | 2 | 2 | — | — | — | 2 |
| Leiomyoma | D007889 | — | D25 | — | 1 | — | — | 1 | 2 |
| Myofibroma | D047708 | — | — | — | 1 | — | — | 1 | 2 |
| Nasopharyngeal carcinoma | D000077274 | — | — | — | 1 | — | — | 1 | 2 |
| Ataxia telangiectasia | D001260 | Orphanet_100 | G11.3 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obstetric labor complications | D007744 | — | — | 1 | — | — | — | 3 | 4 |
| Hypercapnia | D006935 | — | — | 3 | — | — | — | — | 3 |
| Stomatitis | D013280 | EFO_1001904 | K12.1 | 2 | — | — | — | 1 | 3 |
| Cesarean section | D002585 | — | — | 1 | — | — | — | 1 | 2 |
| Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | 1 | 2 |
| Impacted tooth | D014095 | — | K01.1 | 1 | — | — | — | 1 | 2 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | 1 | 2 |
| Marijuana abuse | D002189 | EFO_0007191 | F12 | 2 | — | — | — | — | 2 |
| Recreational drug use | D000084783 | — | — | 2 | — | — | — | — | 2 |
| Obstetrical anesthesia | D000773 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Conduction anesthesia | D000765 | — | — | — | — | — | — | 4 | 4 |
| Thoracic surgical procedures | D019616 | — | — | — | — | — | — | 3 | 3 |
| Laparoscopy | D010535 | — | — | — | — | — | — | 3 | 3 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 2 | 2 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 2 | 2 |
| Infections | D007239 | EFO_0000544 | — | — | — | — | — | 2 | 2 |
| Menorrhagia | D008595 | EFO_0003945 | N92.0 | — | — | — | — | 2 | 2 |
| Hemophilia a | D006467 | EFO_0007267 | D66 | — | — | — | — | 2 | 2 |
| Pneumonia | D011014 | EFO_0003106 | J18 | — | — | — | — | 2 | 2 |
| Hyperaldosteronism | D006929 | — | E26 | — | — | — | — | 2 | 2 |
| Drug common name | Oxycodone |
| INN | oxycodone |
| Description | Oxycodone is a semisynthetic opioid of formula C18H21NO4 that is derived from thebaine. It is a moderately potent opioid analgesic, generally used for relief of moderate to severe pain. It has a role as an opioid analgesic, a mu-opioid receptor agonist and an antitussive. It is an organic heteropentacyclic compound and a semisynthetic derivative. It is functionally related to a thebaine. It is a conjugate base of an oxycodone(1+). It derives from a hydride of a morphinan. |
| Classification | Small molecule |
| Drug class | Opioid |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | COc1ccc2c3c1O[C@H]1C(=O)CC[C@@]4(O)[C@@H](C2)N(C)CC[C@]314 |
| PDB | — |
| CAS-ID | 76-42-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL656 |
| ChEBI ID | 7852 |
| PubChem CID | 5284603 |
| DrugBank | DB00497 |
| UNII ID | CD35PMG570 (ChemIDplus, GSRS) |



























